No single hormone level can definitively confirm perimenopause, but a combination of markers, especially follicle-stimulating hormone (FSH), estradiol, and anti-Müllerian hormone (AMH), can paint a clear picture of where you are in the transition. The challenge is that perimenopausal hormones fluctuate wildly from week to week and even hour to hour, which is why a one-time blood draw rarely tells the whole story.
FSH: The Primary Marker
FSH is the hormone most commonly tested when perimenopause is suspected. Your brain releases FSH to tell your ovaries to produce an egg each cycle. As your ovaries become less responsive with age, your brain compensates by pumping out more FSH, like turning up the volume when someone isn’t listening. That rising FSH is the hallmark hormonal signal of the menopausal transition.
An FSH level above 16 IU/L is generally consistent with perimenopause or postmenopause. In late perimenopause, FSH levels often climb above 25 IU/L. But here’s the catch: during perimenopause, FSH can swing from clearly elevated one month back into the normal premenopausal range the next, especially when estradiol happens to spike. This is why a single FSH reading can be misleading. For the most reliable snapshot, FSH is best measured on day 3 of your menstrual cycle (counting from the first day of your period), when levels are at their baseline for that cycle.
Estradiol: The Fluctuating Hormone
Estradiol is the primary form of estrogen your ovaries produce. Many people assume estradiol simply drops during perimenopause, but the reality is more chaotic. Before it declines for good, estradiol can actually surge to levels 30% higher than normal due to disrupted signaling between the brain and the ovaries. Your body is essentially overcorrecting, sending stronger hormonal signals to ovaries that are becoming less predictable.
In reproductive-age women, estradiol follows a predictable pattern each cycle, rising before ovulation and falling afterward. During perimenopause, that pattern breaks down. You might have a cycle where estradiol spikes unusually high, followed by a cycle where it barely rises at all. Levels below about 60 pg/mL are associated with hot flashes and bone loss, while levels around 100 pg/mL tend to keep those symptoms at bay. Once estradiol consistently stays below 60 pg/mL, you’re likely nearing or past the end of the transition.
AMH: Predicting How Close You Are
Anti-Müllerian hormone is produced by the small follicles in your ovaries. It reflects your remaining egg supply, which makes it useful for estimating how far away menopause might be. Unlike FSH and estradiol, AMH doesn’t fluctuate much throughout your cycle, so it can be tested on any day.
An AMH level below 0.20 ng/mL suggests menopause is roughly 6 to 10 years away, depending on your age. For women aged 40 to 49, an AMH below 0.39 ng/mL has a 90% positive predictive value for approaching menopause. At the very low end, when AMH drops below 0.01 ng/mL, the probability of reaching menopause within the next 12 months ranges from about 51% in women under 48 to 79% in women 51 and older. Conversely, if your AMH is still above 0.1 ng/mL, there’s a 90 to 97% chance you won’t reach menopause in the next year.
AMH is particularly helpful because it gives a longer-range view. FSH tells you what’s happening right now. AMH tells you roughly where you stand in the bigger timeline.
Progesterone: The Quiet Decline
Progesterone gets less attention in perimenopause testing, but its decline often causes symptoms before FSH rises noticeably. Progesterone is produced after ovulation. As perimenopausal cycles become increasingly anovulatory (meaning no egg is released), progesterone production drops or disappears entirely for that cycle. This is what drives many early perimenopausal symptoms like heavier periods, irregular bleeding, sleep disruption, and increased anxiety.
In a normal ovulatory cycle, progesterone peaks about 6 to 8 days after ovulation. Levels are pulsatile, meaning they can swing between 5 and 40 ng/mL within 90 minutes in the same person on the same day. That dramatic variability makes a single progesterone measurement difficult to interpret. A reading below 5 ng/mL in the second half of your cycle suggests you didn’t ovulate that month, which becomes increasingly common in perimenopause. Women of late reproductive age consistently show decreased progesterone production even in cycles where ovulation does occur.
Inhibin B: An Early Warning Signal
Inhibin B is a protein produced by ovarian follicles that helps regulate FSH. It’s not commonly ordered in routine clinical practice, but it’s worth understanding because it drops before FSH rises. Research tracking women over five years before their final period found that inhibin B declines sharply about 2 to 3 years before menopause, and this decline happens at the same time FSH begins its climb. A related protein, inhibin A, starts falling even earlier, about 4 years before the final period. Together, these declining inhibin levels are what allow FSH to rise unchecked.
How Doctors Stage the Transition
The STRAW+10 system is the standard framework clinicians use to define where someone falls in the menopausal transition. It divides the process into stages based on both menstrual cycle changes and hormone levels.
- Early perimenopause (Stage -2): Your cycles start varying in length by 7 days or more compared to your norm. If your cycle was always 28 days and now it’s swinging between 24 and 35, that qualifies. FSH is elevated but variable in this stage. AMH is low.
- Late perimenopause (Stage -1): You start skipping periods entirely, going 60 days or longer between cycles. Hormones fluctuate dramatically. FSH levels sometimes reach the menopausal range (above 25 IU/L) and sometimes drop back to normal, particularly when estradiol happens to spike. AMH falls to undetectable levels. Anovulatory cycles become frequent.
The final menstrual period (Stage 0) can only be identified in hindsight, after 12 consecutive months without a period. No hormone test can tell you in the moment that a given period was your last one.
Why Testing Has Limits
The core problem with hormone testing during perimenopause is that variability is the defining feature of this life stage. Your FSH might read 35 IU/L one month and 12 IU/L the next. Estradiol might be higher than it’s ever been, then plummet. A single blood draw captures one moment in a hormonal landscape that’s shifting constantly.
This is why perimenopause is still largely a clinical diagnosis, meaning it’s based on your symptoms and menstrual patterns rather than lab values alone. If you’re in your 40s or late 30s and your periods have become unpredictable, and you’re experiencing symptoms like hot flashes, sleep changes, or mood shifts, those observations carry as much diagnostic weight as any blood test. Hormone levels are most useful when the clinical picture is ambiguous, for example, if you’ve had a hysterectomy and have no menstrual patterns to track, or if you’re younger than typical and premature ovarian insufficiency is a concern.
When testing is done, a combination of day-3 FSH, estradiol, and AMH provides the most complete hormonal picture. Repeat testing over several months gives more reliable information than any single draw.